Patent directory · USPTO A61K / A61P
Patents matching “Sanaria Inc.”
17 pharma patents match "Sanaria Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 17 pharmaceutical patents matching "Sanaria Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12409213
Live attenuated oral vaccine against shigellosis and typhoid fever
granted -
US 12171822
Infectious plasmodium sporozoites grown in vitro
granted -
US 11883475
Infectious Plasmodium sporozoites grown in vitro
granted -
US 11207395
Infectious plasmodium sporozoites grown in vitro
granted -
US 10441646
Infectious plasmodium sporozoites grown in vitro
granted -
US 10272146
Purified plasmodium and vaccine compositions
granted -
US 9931389
Genetic attenuation of plasmodium by B9 gene disruption
granted -
US 9878026
Infectious plasmodium sporozoites grown in vitro
granted -
US 9642909
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants
granted -
US 9616115
Purified plasmodium and vaccine compositions
granted -
US 9278125
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants
granted -
US 9241982
Purified plasmodium and vaccine compositions
granted -
US 8992944
Purified Plasmodium and vaccine composition
granted -
US 8821896
Purified Plasmodium and vaccine composition
granted -
US 8367810
Purified plasmodium and vaccine compositions
granted -
US 8043625
Purified plasmodium and vaccine compositions
granted -
US 7229627
Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
granted